Baricitinib
- PDF / 168,900 Bytes
- 1 Pages / 595.245 x 841.846 pts (A4) Page_size
- 26 Downloads / 157 Views
1 S
Respiratory infections: case report In a prospective study of 22 patients conducted between October 2017 and March 2019, a patient [age and sex not stated] was described, who developed respiratory infections during treatment with baricitinib for rheumatoid arthritis. The patient who had rheumatoid arthritis commenced on oral baricitinib [exact dosage not stated]. However, the patient developed respiratory infections [duration of treatment to reaction onset and outcome not stated]. The patient continued treatment with baricitinib. Ramirez De La Torre M, et al. Analysis of the effectiveness, safety and predictors of good response of baricitinib in Rheumatoid Arthritis. International Journal of Clinical 803502917 Pharmacy 42: 280-281, No. 1, Jan 2020. Available from: URL: http://doi.org/10.1007/s11096-019-00945-w [abstract]
0114-9954/20/1823-0001/$14.95 Adis © 2020 Springer Nature Switzerland AG. All rights reserved
Reactions 26 Sep 2020 No. 1823
Data Loading...
